---

Daniel O’Connor

Expert Medical Assessor, Medicines and Healthcare products Regulatory Agency

A medical assessor at MHRA, Daniel is instrumental in the UK’s Early Access to Medicines Scheme (EAMS). “It is a privilege to work in a setting where you are contributing positively to public health on a daily basis,” he says. What big change would he like to see in industry? More collaborative working across different stakeholders, including patients, regulators and industry.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018